|
(click on the "Protocol #
" below for additional information on that trial)
|
08C.447 : Breast
Purpose: The purpose of this study is to assess the potential value of SuperSonic Shear Wave Elastography for breast imaging. More specifically, this study aims to determine if this new Elastography mode can improve the characterization and the visualization of breast lesions.
Title: Assessment of the Clinical Value of SuperSonic Shear Wave Elastography in the Ultrasonic Evaluation of Breast Lesions |
08F.481 : Breast
Purpose: The main objective is to compare disease-free survival in patients receiving clodronate versus ibandronate versus zoledronic acid as adjuvant therapy for breast cancer.
Title: S0307 – Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer |
08F.515 : Head & Neck
Purpose: To compare the overall survival of patients with recurrent or metastatic head and neck cancer treated with standard Cisplatin-based chemotherapy with or without Bevacizumab.
Title: E1305 - A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer |
08F.330 : Lung & other Thoracic Malignancies, Breast, Prostate
Title: RTOG#0517 Randomized Phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer
Open to JKCCN only. |
07F.299R : Prostate
Purpose: To study how effective and safe prostate seed implants are for recurrent prostate cancer
Title: A prospective Phase II trial of transperineal ultrasound-guided brachytherapy for locally recurrent prostate adenocarcinoma following external beam radiotherapy - RTOG 0526 |
08F.354 : Prostate
Title: RTOG 0622: A Phase II Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3-D-CRT or IMRT Irradiation in High Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy |
08F.414 : Renal
Purpose: To assess progression-free survival on each arm of combination targeted (CTT) compared to that of bevacizumab alone.
Title: E2804: The BeST Trial: A Randomized Phase II Study of VEGF, RAF Kinase, and mTOR Combination Targeted Therapy (CTT) with Bevacizumab, Sorafenib, and Tensirolimus in Advanced Renal Cell |
